Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.

about

Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.

Item

http://www.wikidata.org/entity/Q52772099

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@en

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@nl

type

Item

label

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@en

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@nl

prefLabel

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@en

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@nl

P1476

Inhibition of cytochrome P450 ...... 201 in human liver microsomes.

@en

P2093

Hee Seung Kim

http://www.w3.org/2001/XMLSchema#string

Hye Suk Lee

http://www.w3.org/2001/XMLSchema#string

Jae Chul Cheong

http://www.w3.org/2001/XMLSchema#string

Ju-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Moon Kyo In

http://www.w3.org/2001/XMLSchema#string

Soon-Sang Kwon

http://www.w3.org/2001/XMLSchema#string

Tae Yeon Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond THC: The New Generation of Cannabinoid Designer Drugs

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.

Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.

URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products.

Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201.

High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.

In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

P2888

s12272-017-0917-y

P304

727-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-017-0917-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28484907

http://www.w3.org/2001/XMLSchema#string